Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The pivotal trial supporting its 2010 FDA approval enrolled 816 HIV-infected adults with clinically defined lipodystrophy, and Phase 3 data documented visceral fat reductions of roughly 15-18% over 26 weeks of treatment a result robust enough to clear FDA review for a defined medical indication
With Strive formulation at 10mg/mL concentration, the conversion is straightforward
Median and range figures below are computed from in-stock observations only
Manual conversions increase the risk of incorrect volumes, which can lead to wasted product and inconsistent results in research
US$ 26.03
US$ 20.98
US$ 22.05
US$ 21.35
US$ 23.38
US$ 25.09
US$ 29.05
US$ 27.47
US$ 20.16
US$ 29.23
![Dimensional Prison [LCGX-EN220] Ultra Rare ARC126-R](https://cdn.shopify.com/s/files/1/0581/0284/1476/products/ecfb82c1-cffb-5a6a-9783-7e40216b1eb1.jpg?v=1649190356)